Methamphetamines clinical trials at UCLA

1 in progress, 0 open to eligible people

Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
Sorry, in progress, not accepting new patients
The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing methamphetamine (MA) use in individuals with moderate or severe methamphetamine use disorder (MUD) seeking to stop or reduce MA use.
Los Angeles, California and other locations

Last updated: July 10, 2026

Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder